Anris Inc
Tokyo, JP · 1 known investors
ANRis is a drug discovery venture developing siRNA nucleic acid therapeutics based on the University of Tokyo's "SNPD-siRNA" technology, which selectively suppresses mRNA carrying single-nucleotide variants. It targets driver-gene mutations to create treatments for cancer, genetic disorders, and other diseases.
Founders & leadership
川渉
川村 渉代表取締役 (Representative Director)
Investors · 1
Frequently asked questions
- What does Anris Inc do?
- ANRis is a drug discovery venture developing siRNA nucleic acid therapeutics based on the University of Tokyo's "SNPD-siRNA" technology, which selectively suppresses mRNA carrying single-nucleotide variants. It targets driver-gene mutations to create treatments for cancer, genetic disorders, and other diseases.
- Who are Anris Inc's investors?
- Anris Inc's investors include Waseda University Ventures.
- Where is Anris Inc headquartered?
- Anris Inc is headquartered in Tokyo, JP.